|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/496 | |
| A61P 15/00 |
| (11) | Patento numeris | 1740180 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 05735420.1 |
| Europos patento paraiškos padavimo data | 2005-04-18 | |
| (97) | Europos patento paraiškos paskelbimo data | 2007-01-10 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2010-07-21 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2005/004086 |
| Data | 2005-04-18 |
| (87) | Numeris | WO 2005/102343 |
| Data | 2005-11-03 |
| (30) | Numeris | Data | Šalis |
| 564660 P | 2004-04-22 | US |
| (72) |
PYKE, Robert, US
|
| (73) |
Boehringer Ingelheim Pharmaceuticals, Inc.,
900 Ridgebury Road, Ridgefield Connecticut 06877,
US
Boehringer Ingelheim Pharma GmbH & Co. KG, Binger Strasse 173, 55216 Ingelheim, DE |
| (54) | USE OF FLIBANSERIN IN THE TREATMENT OF PREMENSTRUAL DISORDERS |
| USE OF FLIBANSERIN IN THE TREATMENT OF PREMENSTRUAL DISORDERS |